Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  1. Outputs

Prognostic value of p 53, c-erb-B2 and MIB-1 in endometrial carcinoma

Academic Article
Publication Date:
2001
Short description:
Prognostic value of p 53, c-erb-B2 and MIB-1 in endometrial carcinoma / Cherchi, P.L., Marras, V., Capobianco, G., Ambrosini, G., Piga, M.D., Fadda, G.m., Rosas, N., Dessole, S.. - In: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. - ISSN 0392-2936. - 22:6(2001), pp. 451-453.
abstract:
OBJECTIVE: To assess the immunohistochemical expression of p53 protein, a tumour suppressor gene of the oncogene c-erb-B2 and MIB-1 proliferation marker (Ki-67 antigen) in endometrial carcinoma.
METHODS:
We studied 29 cases of endometrial carcinoma in which the p53, c-erb-B2 and MIB-1/Ki-67 antigens were investigated by an immunohistochemical method. We evaluated the correlations among the immunohistochemical positivity and the grading, depth of myometrial invasion, stage of the neoplasia and follow-up.
RESULTS:
Both p53 and c-erb-B2 were positive in 16 out of 29 cases (55.2%), whereas MIB-1 was positive in 19 out of 29 cases (65.5%). All these three antigens showed a positive correlation with the grading, myometrial invasion and FIGO stage. Regarding follow-up, p53, c-erb-B2 and MIB-1 were, respectively, positive in 100%, 83.4% and 66.7% of neoplasias of patients who died of disease whereas they were positive in 40%, 40% and 60%, respectively, of tumours of patients with no evidence of disease.
CONCLUSION:
The overexpression of p53, c-erb-B2 and MIB-1 seem to indicate a more malignant tumour phenotype.
Iris type:
1.1 Articolo in rivista
Keywords:
Prognostic value; endometrial carcinoma
List of contributors:
Cherchi, Pier Luigi; Marras, V; Capobianco, Giampiero; Ambrosini, G; Piga, Maria Domenica; Fadda, Gm; Rosas, N; Dessole, Salvatore
Authors of the University:
CAPOBIANCO Giampiero
Handle:
https://iris.uniss.it/handle/11388/47041
Published in:
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.6.2.0